Press release
Parenteral Nutrition Market: Surging from US$ 6 Billion in 2021 to a Projected US$ 14 Billion by 2032
The market for parenteral nutrition accrued significant gains, being valued at over US$ 6 Billion as of 2021.The industry is expected to reach US$ 7 Billion by 2022-end, experiencing year on year increase of 16% compared to 2021. From 2022-2032, the industry is forecast to increase 2x to reach US$ 14 Billion.Parenteral nutrition, a method of delivering essential nutrients directly into the bloodstream, has emerged as a critical component of healthcare for patients unable to receive nutrition through oral or enteral routes. This market has witnessed significant growth and transformation over the years, driven by advancements in medical technology, increasing prevalence of chronic diseases, and a growing aging population. In this article, we explore the key trends, challenges, and opportunities within the parenteral nutrition market.
Get a FREE Sample Copy of Report (Including TOC, List of Tables & Figures, Chart)-https://www.factmr.com/connectus/sample?flag=S&rep_id=7092
Key Companies Profiled
Allergan Plc.
Baxter International
Vifor Pharma Group
Grifols S.A
Otsuka Pharmaceutical Co. Ltd.
Fresenius Kabi
B. Braun Melsungen AG
Pfizer Inc.
Sichuan Kelun Pharmaceutical Co. Ltd.
Actavis Inc.
Market Overview:
The global parenteral nutrition market has experienced steady growth, fueled by the rising incidence of malnutrition, gastrointestinal disorders, and the expanding geriatric demographic. The market encompasses a wide range of products, including parenteral nutrition solutions, equipment, and services. Intravenous lipid emulsions, amino acids, carbohydrates, electrolytes, and vitamins are among the essential components delivered through parenteral nutrition.
Key Drivers:
Rising Incidence of Chronic Diseases:Chronic illnesses, such as cancer, gastrointestinal disorders, and inflammatory bowel diseases, often lead to malnutrition. Parenteral nutrition becomes a vital intervention in such cases, providing the necessary nutrients directly to the bloodstream, bypassing the compromised digestive system.
Aging Population:The global population is aging, resulting in an increased prevalence of conditions that necessitate parenteral nutrition. Older adults may face challenges in nutrient absorption or have difficulty swallowing, making parenteral nutrition a crucial option for ensuring adequate nourishment.
Technological Advancements:Advances in medical technology have improved the safety and efficacy of parenteral nutrition delivery systems. Innovations in infusion pumps, catheters, and compounding technologies have enhanced the precision and reliability of nutrient administration, reducing the risk of complications.
Customization and Personalization:The shift towards personalized medicine is influencing the parenteral nutrition market. Healthcare providers are increasingly tailoring parenteral nutrition formulations based on individual patient needs, considering factors such as age, weight, and specific medical conditions.
Challenges:
Regulatory Hurdles:Stringent regulatory requirements pose challenges for market players, particularly in terms of product approval and compliance. The need for adherence to quality standards and rigorous testing contributes to a complex regulatory landscape.
High Costs:Parenteral nutrition products and associated equipment can be costly. This poses a financial challenge for both healthcare facilities and patients, potentially limiting access to these critical interventions.
Complications and Risks:While parenteral nutrition is a life-saving intervention, it is not without risks. Complications such as infections, metabolic imbalances, and catheter-related issues can occur, necessitating careful monitoring and management.
Opportunities:
Home-Based Parenteral Nutrition:The growing trend towards home-based healthcare creates opportunities for the expansion of parenteral nutrition services beyond traditional hospital settings. Home infusion services and advancements in portable infusion pumps enable patients to receive parenteral nutrition in the comfort of their homes.
Collaborations and Partnerships:Strategic collaborations between pharmaceutical companies, medical device manufacturers, and healthcare providers can foster innovation and address challenges within the parenteral nutrition market. These partnerships may lead to the development of novel formulations and technologies.
Focus on Research and Development:Continued investment in research and development is crucial for addressing current limitations and exploring new avenues within parenteral nutrition. This includes the development of alternative delivery methods, improved formulations, and enhanced monitoring systems.
More Healthcare Related Report-
Bipolar Disorder Therapeutics Market- https://www.factmr.com/report/bipolar-disorder-therapeutics-market
Insulin Pumps Market- https://www.factmr.com/report/insulin-pumps-market
Liposuction Surgery Devices Market- https://www.factmr.com/report/liposuction-surgery-devices-market
Dental Services Market-https://www.factmr.com/report/dental-services-market
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com
About Fact.MR
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Parenteral Nutrition Market: Surging from US$ 6 Billion in 2021 to a Projected US$ 14 Billion by 2032 here
News-ID: 3369694 • Views: …
More Releases from Fact.MR

Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decoding…

Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke …
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleaners…

Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offering…

Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 …
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhance…
More Releases for Parenteral
Small Volume Parenteral Market Future Business Opportunities 2025-2032 | Freseni …
Global Small Volume Parenteral Market is estimated to be valued at USD 207.57 Bn in 2025 and is expected to reach USD 344.37 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 7.5% from 2025 to 2032.
The qualitative latest Research report (2025-2032) on the Small Volume Parenteral Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes…
Major Force in the Self-Administered Parenteral Market 2025: Chronic Diseases Fu …
How Will the Self-Administered Parenteral Market Grow, and What Is the Projected Market Size?
The self-administered parenteral market has experienced strong growth in recent years. It will rise from $24.57 billion in 2024 to $26.04 billion in 2025, at a CAGR of 6.0%. This growth is driven by the rise in chronic diseases, the aging population, government initiatives, patient education and support programs, and the increasing incidences of bone disorders.
The self-administered…
Advanced Parenteral Drug Delivery Devices Market - Setting the Standard in Advan …
Newark, New Castle, USA: The "Advanced Parenteral Drug Delivery Devices Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Advanced Parenteral Drug Delivery Devices Market: https://www.growthplusreports.com/report/advanced-parenteral-drug-delivery-devices-market/7844
This latest report…
Normal Saline for Parenteral Use Market - Empowering Wellness: Normal Saline for …
Newark, New Castle, USA: The "Normal Saline for Parenteral Use Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Normal Saline for Parenteral Use Market: https://www.growthplusreports.com/report/normal-saline-for-parenteral-use-market/8616
This latest report…
Parenteral Packaging Market is Segmented By Packaging Type - small Volume Parent …
Manufacturers of parenteral packaging products are moving away from the ‘drugs for container’ concept and are focusing on providing ‘containers for drugs’ – implying the adoption of appropriate materials to manufacture parenteral containers. The 3P’s driving the global parenteral packaging market are Product, Process, and Patient, and given the increasing focus on sustainability and green initiatives, plastic is slowly being eliminated from the parenteral packaging ecosystem. Companies are shifting towards prefilled and…
Parenteral Nutrition Market Research Report 2024
Braun Melsungen AG, Fresenius SE & Co. KGaA, and Baxter International, Inc., who collectively held 71% of the global parenteral nutrition market, are focusing on improving their line of products, reports Transparency Market Research. The trend of winning approvals for their new formulations from concerned authorities is also helping them gain a significant footprint in the market, observes TMR.
Strategic joint ventures are also being considered by companies to expand their…